Cargando…
Gasotransmitter-Induced Therapeutic Angiogenesis: A Biomaterial Prospective
[Image: see text] Gasotransmitters such as NO, H(2)S, and CO have emerged as key players in the regulation of various pathophysiological functions, prompting the development of gas therapy for various pathogeneses. Deficient production of gasotransmitters has been linked to various diseases such as...
Autores principales: | Robert, Becky, Subramaniam, Sadhasivam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773187/ https://www.ncbi.nlm.nih.gov/pubmed/36570231 http://dx.doi.org/10.1021/acsomega.2c05599 |
Ejemplares similares
-
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
por: Chen, Yingqing, et al.
Publicado: (2021) -
Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2021) -
The Role of Gasotransmitters in Gut Peptide Actions
por: Verbeure, Wout, et al.
Publicado: (2021) -
Gasotransmitter modulation of hypoglossal motoneuron activity
por: Browe, Brigitte M, et al.
Publicado: (2023) -
Gasotransmitters, poisons, and antimicrobials: it's a gas, gas, gas!
por: Tinajero-Trejo, Mariana, et al.
Publicado: (2013)